The next step in Zeneca's research called for another service conveniently available at Incyte.
Moreover, Durand later filed suit making similar allegations against a TAP rival, the former Zeneca Inc.
In Britain, Zeneca is working with the Science Museum on a Future Food exhibition.
ECONOMIST: Marketing weird stuff: I’m modified, buy me | The
Zeneca's switch-hitting maize plants are now being tested to see how useful they are for hybrid-seed production.
By 1999 Zeneca had devised a drug, Iressa, that interrupted the pathways between EGF and tyrosine kinase.
Zeneca established its oncology business with the launch in 1973 of Nolvadex, the first treatment targeting breast cancer.
Zeneca does this by genetically engineering its maize to produce an enzyme, called ribonuclease, which interferes with pollen production.
Zeneca had established its oncology business with the 1973 launch of Nolvadex, the first targeted treatment for breast cancer.
Durand joined the company in January 1995 just as Lupron was facing fierce competition, from Zeneca's Zoladex, a lower-cost rival.
Zeneca's approach got a boost in late 1998 with the approval of Herceptin , a Genentech drug for advanced breast cancer.
This generic version of Astra-Zeneca's Prilosec (for heartburn), the world's bestselling pharmaceutical, is likely to go on the market next year.
Drug firm Astra Zeneca is closing its Loughborough research base at the end of 2011 with the loss of 1, 300 jobs.
Durand began supplying the lawyer with TAP documents, letters with the company's attorneys and memos it exchanged with its archrival, Zeneca.
About 400 of the 1, 300 staff at the site are expected to take retirement or be relocated to other Astra Zeneca sites.
The accumulating data led researchers at Zeneca Group, now AstraZeneca, to wonder whether blocking EGF receptors with a drug might slow tumor growth.
Here's how Zeneca, a London-based pharmaceuticals firm, went about using Incyte to help it discover a drug that would bust bacteria without hurting humans.
For example, Zeneca has managed to switch the bt gene, which gives maize plants resistance to nasty insects, on and off using another chemical trigger.
Such plans worry western drug executives such as John Murdoch of Zeneca, a British firm, who is chairman of the China Foreign Pharmaceutical Industry Association.
Durand had never worked at Zeneca but says he sued the firm at the recommendation of Philadelphia Assistant U.S. Attorney James Sheehan, a former colleague of his attorney.
Directing a team of 50 scientists at Zeneca's labs in Cheshire, U.K., McKillop collected urine samples from employees to isolate EGF and come up with a compound that could effectively block its activity.
McKillop directed a team of 50 scientists at Zeneca's labs in Cheshire, U.K., that collected urine samples from employees to isolate EGF and come up with a compound that could effectively block its activity.
Among them is Zeneca, where researchers are working on a way of controlling male fertility in maize for the production of hybrids a sort of green vasectomy that can be turned on and off at will.
Shares in Zeneca, the British firm that makes the drug, initially rose but then fell when it became clear that Zeneca's patent on the drug has already run out in Europe and runs out in America in 2002.
Simon Best, former head of plant science at Zeneca, looks forward to the day when molecular switches might be so sophisticated that the process of infection or drought will itself be enough to turn on a genetically engineered resistance gene.
Zeneca ordered a "wet" copy of a promising gene, in the form of a clone -- a colony of bacterial cells whose members all carry the desired snippet of DNA. These bacterial guinea pigs can then be used to try out antibacterial chemicals.
应用推荐